THE USE OF DEXMEDETOMIDINE IN COMBINATION NEFOPAM FOR POSTOPERATIVE ANALGESIA AFTER LAPAROSCOPIC CORRECTION OF MORBID OBESITY

Aim. To study the possibility of using a combination of dexmedetomidine with nefopam for postoperative analgesia in patients with morbid obesity after bariatric surgery in anesthesia quality aspects and the impact of the study on the combination during the inflammatory response to surgical trauma. Subjects and methods. A prospective cohort study of 48 patients with obesity. Results. Based on the analysis of hemodynamic parameters, evaluation of pain using a numeric rating scale pain concluded that selective agonist of α-2 adrenergic dexmedetomidine in combination with nefopam provides effective postoperative pain relief in patients who underwent bariatric surgery, and is not a factor for suppression of postoperative inflammatory response Unlike the effects of ketorolac tromethamine, do not always provide a sufficient level of analgesia and reduce the rate of growth in the level of IL-6. Conclusion. The combination of dexmedetomidine with nefopam provides sufficient analgesic effect after bariatric surgery, with noted a more rapid onset of analgesia than with ketorolac. Postoperative analgesia and dexmedetomidine nefopam, unlike the use of ketorolac tromethamine, are not violated ratio of interleukins 1 and 6 was not a factor and suppression of postoperative acute phase inflammatory response.

morbid obesity, pain, bariatric surgery, Interleukin-1, Interleukin-6, Nefopamum, Dexmedetomidinum

1. Adams T. D., Gress R. E., Smith S. C., et al. Long-term mortality after gastric bypass surgery // N. Engl. J. Med. - 2007. - Vol.357. - P 753-761.

2. Batistich S, Kendall A, Somers S. Analgesia requirements in morbidly obese patients // Anaesthesia. 2004. - Vol. 59. - P. 510-511.

3. Covindarajan R., Ghosh B., Sathyamoorthy M. K., et al. Efficacy of ketorolac in lieu of narcotics in the operative management of laparoscopic surgery for morbid obesity // Surg Obes Relat Dis. 2005. Vol. 1. - P. 530-535.

4. Greenstein AJ, Wahed AS, Adeniji A, Courcoulas AP, Dakin G, Flum DR, et al. Prevalence of adverse intraoperative events during obesity surgery and their sequelae // J Am Coll Surg. 2012. - Vol. 215. - P.271-277.

5. Hanley MJ, Abernethy DR, Greenblatt DJ. Effect of obesity on the pharmacokinetics of drugs in humans // Clin Pharmocokinet. 2010. Vol. 49. - P. 71-87.

6. Kamelgard JI, Kim KA, Atlas G. Combined preemptive and preventive analgesia in morbidly obese patients undergoing open gastric bypass: a pilot study // Surg Obes Relat Dis. 2005 Vol. 1. - P.12-16.

7. Lloret-Linares C, Lopes A, Decleves X, Serrie A, Mouly S, Bergmann J-F, Perrot S. Challenges in the optimization of post-operative pain management with opioids in obese patients: a literature review // Obes Surg. 2013. Vol. 23. - P. 1458-1475.

8. Malik V. S., Malik V. S., Willett W. C., Hu F. B. Global obesity: trends, risk, factors and policy implications // Nat. Rev. Endocrinol. 2013. - Vol. 9. - P.13-27.

9. Tufanogullari B., White P. F., Peixoto M. P. et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables // Anesth. Analg. 2008. - Vol.106. - P.1741-1748.